logo-loader
viewWeedMD Inc

WeedMD closes on acquisition of medical cannabis company Starseed

Concurrent with the closing, WeedMD also completed a private placement with the Labourers’ Pension Fund of Central and Eastern Canada for proceeds of C$25 million

WeedMD Inc - WeedMD Inc closes on acquisition of medical cannabis company Starseed Holdings Inc
Starseed provides cannabis for insured patients through their benefit plans

WeedMD Inc (CVE:WMD) (OTCMKTS:WDDMF) has closed on its acquisition of medical cannabis company Starseed Holdings Inc.

Concurrent with the closing, WeedMD also completed the previously announced private placement of subscription receipts with the Labourers’ Pension Fund of Central and Eastern Canada (LPF), for aggregate gross proceeds of C$25 million. 

The issue price of each receipt is C$1.0832, and will be automatically exchangeable into one WeedMD common share following shareholder approval at a meeting scheduled for February 4, 2020, according to a statement.

READ: WeedMD inks blockbuster deal with Starseed Holdings to become major player in the medical cannabis sector

“We officially welcome the Starseed team to the WeedMD family, which together will kick-off 2020 as a very compelling, vertically-integrated cannabis company that will execute across the entire value chain,” said Keith Merker, CEO of WeedMD. 

“Starseed’s unique medical distribution platform complements WeedMD’s high-quality cultivation and processing platform. This partnership, along with the C$25 million strategic equity investment by LPF, positions WeedMD and its shareholders with a fortified balance sheet and one of the most captive medical cannabis businesses in the country as we enter the new year.”

Starseed is a medically focused, federally licensed company that provides cannabis for insured patients through their benefit plans.

Starseed gives WeedMD access to a built-in partnership with Canada’s largest construction union to provide medical cannabis as a fully-covered drug benefit for its more than 100,000 members and retirees in addition to their respective dependents.

For Starseed, the transaction means it is able to move off expensive and unreliable third-party supply and instead drawdown on WeedMD’s reliable, low cost and quality product.

WeedMD also said it has integrated Starseed’s management team into its senior leadership as follows:

  • Keith Merker, CEO (maintains role)
  • Angelo Tsebelis, formerly president of Starseed, assumes the role of president of WeedMD
  • Nichola Thompson, CFO (maintains role)
  • Stephen Ng, formerly CFO of Starseed, is appointed to chief strategy officer of WeedMD
  • Dr Peter Blecher, formerly chief medical officer of Starseed, assumes the role of CMO of WeedMD

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Quick facts: WeedMD Inc

Price: 0.45 CAD

TSX-V:WMD
Market: TSX-V
Market Cap: $94.31 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of WeedMD Inc named herein, including the promotion by the Company of WeedMD Inc in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks off to slow start to the holidays; WeedMD rises...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, fell 1.8% to settle at 115.4 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF lost 2.1% at C$8.99, while the OTCQX Cannabis dropped 2.3% at 444.7 points. Buds today are WeedMD Inc...

on 12/02/2019

2 min read